Vantage logo

Biotech’s near-term key catalysts

Important data reveals are expected from Madrigal, Arrowhead and Ascendis, with details from Biogen and Eisai due at a conference.

Vantage logo

Esmo 2022 – double trouble for Lumakras

Key data omitted from Codebreak-200’s late-breaking abstract reveal cases of drug-induced liver injury, and overall survival that points the wrong way.